Mirabella Financial Services’s Edwards Lifesciences EW Stock Holding History

Mirabella Financial Services’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,349	Closed	-$589K	–	842
2026 Q1	$589K	Buy	7,349 +3,413	+87%	+$281K	0.06%	228
2025 Q4	$336K	Buy	+3,936	New	+$323K	0.03%	419
2024 Q4	–	Sell	-89,849	Closed	-$5.93M	–	248
2024 Q3	$5.93M	Buy	+89,849	New	+$6.53M	0.33%	50
2023 Q1	–	Sell	-81,598	Closed	-$6.09M	–	455
2022 Q4	$6.09M	Buy	+81,598	New	+$6.29M	0.54%	25
2021 Q2	–	Sell	-17,602	Closed	-$1.47M	–	330
2021 Q1	$1.47M	Buy	+17,602	New	+$1.49M	0.46%	64

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Mirabella Financial Services's EW Position: Q2 2026 in Review

Mirabella Financial Services sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 7,349 shares — an estimated $589K sold.

Mirabella Financial Services first reported a position in EW in Q1 2021 and held it in 5 quarters. The position peaked at $6.09M in Q4 2022. 1,326 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Mirabella Financial Services reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
Mirabella Financial Services sold 7,349 Edwards Lifesciences shares in Q2 2026, an estimated $589K.
Mirabella Financial Services first reported a position in Edwards Lifesciences in Q1 2021 and held it in 5 quarters.
Mirabella Financial Services's Edwards Lifesciences position peaked at $6.09M in Q4 2022.
1,326 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.